Condition
Refractory Epilepsy in Children
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 3 (1)
Trial Status
Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07668856Phase 3RecruitingPrimary
Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
NCT07064421RecruitingPrimary
Non-Helium Magnetoencephalography in Pediatric Refractory Epilepsy
NCT01378611Phase 2UnknownPrimary
Does VNS Interact With the Serotonergic and Immune System in Children With Intractable Epilepsy?
Showing all 3 trials